- NEWS AND VIEWS
Second example reported of a stem-cell transplant in the clinic leading to HIV remission
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 568, 175-176 (2019)
doi: https://doi.org/10.1038/d41586-019-00989-y
References
Hütter, G. et al. N. Engl. J. Med. 360, 692–698 (2009).
Gupta, R. K. et al. Nature 568, 244–248 (2019).
Symons, J. et al. Clin. Infect. Dis. 59, 596–600 (2014).
Kordelas, L. et al. N. Engl. J. Med. 371, 880–882 (2014).
Verheyen, J. et al. Clin. Infect. Dis. 68, 684–687 (2019).
Henrich, T. J. et al. J. Infect. Dis. 207, 1694–1702 (2013).
Henrich, T. J. et al. Ann. Intern. Med. 161, 319–327 (2014).
Cummins, N. W. et al. PLoS Med. 14, e1002461 (2017).
Salgado, M. et al. Ann. Intern. Med. 169, 674–683 (2018).
Harrigan, P. R., Whaley, M. & Montaner, J. S. AIDS 13, F59–F62 (1999).
Li, J. Z. et al. AIDS 30, 343–353 (2016).
Yukl, S. A. et al. PLoS Pathog. 9, e1003347 (2013).
Competing Interests
The author does consulting for Merck and receives grant support from Gilead Biosciences.